Keywords
Key points
- •Severe acute respiratory virus coronavirus 2 virus traumatized New York in March and April of 2020 and the coronavirus disease 19 (COVID-19) pandemic left an indelible mark on the majority of individuals particularly, in New York City.
- •There are 2 major categories of tests used to detect current or past viral infection: molecular and serologic assays.
- •Molecular assays are designed to determine whether a patient is actively infected with a pathogen of interest.
- •Serologic assays determine a patient's exposure history.
Introduction
Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome, in NCBI Reference Sequence: NC_045512.2. 2019. Available at: https://www.ncbi.nlm.nih.gov/nuccore/1798174254.
Laboratory tests for detection of severe acute respiratory virus coronavirus 2


Preanalytical Variables of Severe Acute Respiratory Virus Coronavirus 2 Diagnostics
Prevention, C.o.D.C.a., Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
- Kucirka L.M.
- Lauer S.A.
- Laeyendecker O.
- et al.
- Rogers A.A.
- Baumann R.E.
- Borillo G.A.
- et al.
- Joung J.
- Ladha A.
- Saito M.
- et al.
Rapid point-of-care molecular assays
- Harrington A.
- Cox B.
- Snowdon J.
- et al.
- Zhen W.
- Smith E.
- Manji R.
- et al.
- Basu A.
- Zinger T.
- Inglima K.
- et al.
Serologic assays for coronavirus disease 19

- Zhao J.
- Yuan Q.
- Wang H.
- et al.
Considerations for Laboratory Testing During Unprecedented Times of Community Infections
Disclosure
References
Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome, in NCBI Reference Sequence: NC_045512.2. 2019. Available at: https://www.ncbi.nlm.nih.gov/nuccore/1798174254.
- World Health Organization Coronavirus disease (COVID-19) Pandemic.(Available at:) (Accessed May 26th, 2020)
- Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study.Pneumonia (Nathan). 2017; 9: 4https://doi.org/10.1186/s41479-017-0028-z
- Coronavirus and the race to distribute reliable diagnostics.Nat Biotechnol. 2020; 38: 382-384
- New York State Department of Health COVID-19 Tracker.(Available at:)https://covid19tracker.health.ny.gov/(Accessed May 26th, 2020)Date: 2020
- Emergency Use Authorizations.(Available at:) (Accessed May 26th, 2020)
Prevention, C.o.D.C.a., Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
- Comparison between saliva and nasopharyngeal swab specimens for detection of respiratory viruses by multiplex reverse transcription-PCR.J Clin Microbiol. 2017; 55: 226-233
- Patient-collected tongue, nasal, and mid-turbinate swabs for SARS-CoV-2 yield equivalent sensitivity to health care worker collected nasopharyngeal swabs.medRxiv. 2020; (04.01.20050005)
- Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure.Ann Intern Med. 2020; https://doi.org/10.7326/M20-1495
- Virological assessment of hospitalized patients with COVID-2019.Nature. 2020; 581: 465-469
- Laboratory diagnosis of emerging human coronavirus infections – the state of the art.Emerg Microbes Infect. 2020; 9: 747-756
- Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR.J Clin Microbiol. 2020; https://doi.org/10.1128/JCM.00708-20
- Development of reverse transcription loop-mediated isothermal amplification assays targeting severe acute respiratory syndrome coronavirus 2.J Mol Diagn. 2020; 22: 729-735
- Point-of-care testing for COVID-19 using SHERLOCK diagnostics.medRxiv. 2020; (05.04.20091231)https://doi.org/10.1101/2020.05.04.20091231
- Comparison of cepheid xpert xpress and abbott id now to roche cobas for the rapid detection of SARS-CoV-2.J Clin Virol. 2020; 128: 104428
- Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.J Clin Microbiol. 2020; https://doi.org/10.1128/JCM.00798-20
- Evaluation of the COVID19 ID NOW EUA assay.J Clin Virol. 2020; 128: 104429
- Clinical evaluation of three sample-to-answer platforms for the detection of SARS-CoV-2.J Clin Microbiol. 2020; https://doi.org/10.1128/JCM.00783-20
- Performance of the rapid Nucleic Acid Amplification by Abbott ID NOW COVID-19 in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution.bioRxiv. 2020; (05.11.089896)https://doi.org/10.1128/JCM.01136-20
- U.S. Food and Drug Administration Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments.(Available at:) (Accessed May 26th, 2020)
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.Clin Infect Dis. 2020; https://doi.org/10.1093/cid/ciaa344
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.Lancet Infect Dis. 2020; 20: 565-574
- Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.Rev Med Virol. 2020; 30: e2107
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020; 395: 507-513
- p24 revisited: a landscape review of antigen detection for early HIV diagnosis.AIDS. 2018; 32: 2089-2102
- Laboratories and pandemic preparedness: A framework for collaboration and oversight.J Mol Diagn. 2020; 22: 841-843